Details on Electronic Prescriptions and Electronic Health Records Requirements for the Electronic Medical Information Linkage System Maintenance and Enhancement Addition Revealed – Questions and Answers 4 [FY2026 Medical Fee Revision] (4) – GemMed

News Highlights

In the Questions and Answers (4) regarding the FY2026 medical fee revision, detailed requirements for electronic prescriptions, electronic health records, etc., for the Electronic Medical Information Linkage System Maintenance and Enhancement Addition were presented. This clarifies the specific standards for medical institutions to establish information linkage systems and claim the addition. M&A and business succession issues that can be inferred from this news include medium- to long-term management and succession strategies with an eye on the revision cycle, economies of scale through group participation, and utilization of tax incentives, including conversion to specific medical corporations and social medical corporations.

Perspective from M&A Medical Editorial Department

The revelation of the detailed requirements for the “Electronic Medical Information Linkage System Maintenance and Enhancement Addition” in the FY2026 medical fee revision signifies more than just a system change. This addition suggests that the status of digital infrastructure, such as electronic prescriptions and electronic health records, is directly linked to the revenue of medical institutions. In particular, it can be said that we have entered an era where more advanced management and succession strategies are required, such as the establishment of regional medical cooperation promotion corporations, the distribution of investment burdens through group corporatization, and conversion to specific medical corporations and social medical corporations.

Medical institutions that are slow to adapt to digitalization may not only face disadvantages in terms of medical fees but also affect their valuation in future M&A. Early digital investment and the accompanying strengthening and review of organizational structures will be key to maintaining future competitiveness.

Issues Highlighted by This News

• The calculation requirements for the Electronic Medical Information Linkage System Maintenance and Enhancement Addition directly influence the ROI of digital investments.
• The introduction and linkage of electronic prescriptions and electronic health records will be important indicators for measuring the profitability and future prospects of medical institutions.
• Group corporatization and participation in regional medical cooperation promotion corporations lead to reduced cost burdens for digital infrastructure development and strengthened collaboration.
• Trends in medical fee revisions may affect the valuation and negotiation terms in M&A of medical institutions.

Practical Questions Arising from This News

• Can the electronic health record system currently in use meet the requirements of this addition?
• What are the merits and demerits of introducing electronic prescriptions in our institution’s regional cooperation?
• When considering group formation or changes in corporate form, what tax merits and demerits can be considered?

If You Feel “Should I Consult Too?”

The requirements for the Electronic Medical Information Linkage System Maintenance and Enhancement Addition shown in this medical fee revision indicate that digital investment is directly linked to management. If you feel that you need to review your medium- to long-term management and succession strategies, including whether your institution’s system can meet the requirements, how to distribute future equipment investment burdens, and tax benefits from group formation or changes in corporate form, it is a good time to consider consulting with an expert.

M&A Medical (CentralMedience Inc.) supports the succession of business for medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation is available here.